Skip to main content
    The obesity clinic
    Menu closed
    GLP-1
    Wegovy
    Mounjaro
    +3

    Published 7 January 2026 · 12 minutes reading time

    GLP-1 medication comparison 2026: Wegovy, Mounjaro, Rybelsus, Ozempic

    A clear comparison of GLP-1 medications for weight loss in Sweden. Effects, side effects, pricing, and who each option fits best.

    GLP-1 medication comparison - Wegovy Mounjaro Rybelsus Ozempic

    Quick answer

    GLP-1 options differ by indication, dose, and delivery method. A medical assessment helps match the right medication to your health profile.

    DD

    Dr. Dorél Lehrer

    Licensed Physician

    Medical Director at Viktenheten
    Experienced in medical weight management

    Verifierad av Socialstyrelsen

    Medicinskt granskad: 7 January 2026

    There are several GLP-1 medications on the market. This overview compares the most common options and who they may suit.

    Injectable vs oral options

    Wegovy and Mounjaro are weekly injections, while Rybelsus is an oral tablet approved for diabetes.

    Effect and dosing

    Higher doses and dual agonists can lead to greater weight loss, but dosing must be individualized.

    Access and pricing

    Prescription requirements and pricing vary. We help evaluate the best option for your needs.

    Ready for the Next Step?

    Our physicians help you develop a safe and evidence-based plan for medical weight treatment.

    Book a consultation

    Related Articles

    View all articles
    7 January 2026

    Mounjaro vs Wegovy - which is right for you?

    Read article
    7 January 2026

    Wegovy vs Ozempic - doctor explained

    Read article
    7 January 2026

    Rybelsus - oral GLP-1 guide

    Read article

    Discover more

    Part of Curevo Health

    Viktenheten is part of Curevo Health, Sweden’s digital specialist care platform.